next article

Vietnamese-American pharma billionaire debuts in 'Forbes 400' list
By Thanh Nien News -

Vietnamese American pharma billionaire Hoang Kieu. Photo: Dao Ngoc Thach Vietnamese American pharma billionaire Hoang Kieu. Photo: Dao Ngoc Thach

Vietnamese-born pharmaceutical billionaire Hoang Kieu has for the first time been named in Forbes Magazine’s 34th annual "Forbes 400" list.
The list ranks America's billionaires who have a combined net worth of US$2.34 trillion.
Hoang Kieu, 71, is at number 149 with a net worth of $3.7 billion. He’s the richest newcomer on this year's list.
According to Forbes, Hoang Kieu was born in Vietnam and immigrated to the US with his family in 1975 after the Vietnam War ended. He found his way into a job at Abbott Reference Laboratories in California, and became director of the company's blood plasma testing and manufacturing division.
In 1980 he founded a company called Rare Antibody Antigen Supply and began to acquire plasma centers in the US. He started to collaborate with the Shanghai Blood Center in China in 1987. That led him to found Shanghai RAAS Blood Products in 1992, which supplies albumin, immunoglobulin and other blood-derived products. It trades on the Shenzhen stock exchange.
He is vice chairman of Shanghai RAAS, and owns about 35 percent of the Shenzhen-listed company.
He lives in Westlake Village in southern California. In 2014 he bought a winery and vineyards from the Mondavi Family Estate in Napa Valley, and now operates the Kieu Hoang Winery, the report said.
The billionaire has donated some $1 million for poverty relief in Vietnam.
This year Vietnamese property tycoon Pham Nhat Vuong has been listed for the third time in Forbes magazine's annual ranking of global billionaires. 
Forbes released its annual accounting of the world’s richest people, all 1,826 billionaires with more than $7 trillion among them, in March. 
Vietnam's only entry, Pham Nhat Vuong, founder and chairman of Vingroup, was ranked 1,118th with a net worth of $1.7 billion, dropping 26 notches from last year.